Seeking Alpha

Alnylam Pharmaceuticals (ALNY): Q4 EPS of -$0.33 in-line. Revenue of $20.5M (-3.5% Y/Y) misses...

Alnylam Pharmaceuticals (ALNY): Q4 EPS of -$0.33 in-line. Revenue of $20.5M (-3.5% Y/Y) misses by $0.4M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)